Alan Berg
Hematology & Oncology · Lincoln, NENPI 1164412425
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $302 of the $372 with a category attached, or 81.2%. 10 manufacturers reported payments, led by Genentech USA, Inc. at 24.8% of the total. Reporting peaked in 2019 at $293 and has fallen 83.8% since, to $47 in 2022. That places this record below the midpoint for hematology & oncology clinicians in NE, where the typical reported total is $3,016.
Across 21 payments — averaging $17.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$92
- Pharmacyclics LLC, An Abbvie Company$70
- Merck$46
- Novartis$34
- Astellas Pharma US Inc$34
- Pfizer$23
- plus $74 from 4 others
Across 118 payments — averaging $3356.15 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$323K
- Bristol Myers Squibb$34K
- Pharmacyclics LLC, An Abbvie Company$17K
- Incyte Corporation$12K
- EMD Serono, Inc.$5K
- Astrazeneca UK Limited$3K
- plus $1K from 1 others
What the payments were for
- Food & beverage$30281%
- Education$7019%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 6 | $92 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $70 |
| Merck | 4 | $46 |
| Novartis | 2 | $34 |
| Astellas Pharma US Inc | 2 | $34 |
| Pfizer | 2 | $23 |
| Johnson & Johnson | 1 | $20 |
| EMD Serono, Inc. | 1 | $19 |
| Sanofi | 1 | $18 |
| Adaptive Biotechnologies Corporation | 1 | $18 |
How this compares
$372 in reported general payments places this provider in the 15th percentile of 73 hematology & oncology providers in Nebraska.
Other hematology & oncology in Lincoln
- Madhu MidathadaLincoln$24K
- Steven DunderLincoln$20K
- Kailash MosalpuriaLincoln$17K
- Nathan GreenLincoln$10K
- Melissa CetakLincoln$6K
- Eric AveryLincoln$6K
- Wallace PetersonLincoln$5K
- Amanda BauerLincoln$5K
- Joni TilfordLincoln$4K
- Kathleen TonkinLincoln$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.